Anika Therapeutics, Inc. Research and Development Expense
Anika Therapeutics, Inc. (ANIK) reported Research and Development Expense of $7.34 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-29.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2026-07-29
- Anika Therapeutics, Inc. research and development expense for the quarter ending 2026-06-30 was $7.34M, a 16.28% increase year-over-year.
- Anika Therapeutics, Inc. research and development expense for the quarter ending 2026-03-31 was $6.71M, a 10.79% increase year-over-year.
- Anika Therapeutics, Inc. research and development expense for the quarter ending 2025-12-31 was $6.45M, a 0.85% decline year-over-year.
- Anika Therapeutics, Inc. research and development expense for the quarter ending 2025-09-30 was $6.95M, a 16.82% increase year-over-year.
- Anika Therapeutics, Inc. research and development expense for fiscal 2025 was $25.77M, a 0.88% increase from fiscal 2024.
- Anika Therapeutics, Inc. research and development expense for fiscal 2024 was $25.54M, a 17.37% increase from fiscal 2023.
- Anika Therapeutics, Inc. research and development expense for fiscal 2023 was $21.76M, a 18.79% increase from fiscal 2022.
- Anika Therapeutics, Inc. research and development expense for fiscal 2022 was $18.32M, a 32.96% decline from fiscal 2021.
| Period end | Research and Development Expense 3 month | Research and Development Expense 3 month as first filed | Research and Development Expense 6 month | Research and Development Expense 6 month as first filed | Research and Development Expense 9 month | Research and Development Expense 9 month as first filed | Research and Development Expense 12 month | Research and Development Expense 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $7.34M 10-Q · filed 2026-07-29 | $14.05M 10-Q · filed 2026-07-29 | $20.51M derived: sum of 3 quarters · filed 2026-07-29 | $27.45M derived: sum of 4 quarters · filed 2026-07-29 | ||||
| 2026-03-31 | $6.71M 10-Q · filed 2026-04-30 | $13.16M derived: sum of 2 quarters · filed 2026-04-30 | $20.11M derived: sum of 3 quarters · filed 2026-04-30 | $26.42M derived: sum of 4 quarters · filed 2026-07-29 | ||||
| 2025-12-31 | $6.45M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | $13.40M derived: sum of 2 quarters · filed 2026-03-03 | $19.71M derived: sum of 3 quarters · filed 2026-07-29 | $25.77M 10-K · filed 2026-03-03 | ||||
| 2025-09-30 | $6.95M 10-Q · filed 2025-11-05 | $13.26M derived: sum of 2 quarters · filed 2026-07-29 | $19.32M 10-Q · filed 2025-11-05 | $25.82M derived: sum of 4 quarters · filed 2026-07-29 | ||||
| 2025-06-30 | $6.31M 10-Q · filed 2026-07-29 | $12.37M 10-Q · filed 2026-07-29 | $18.88M derived: sum of 3 quarters · filed 2026-07-29 | $24.82M derived: sum of 4 quarters · filed 2026-07-29 | ||||
| 2025-03-31 | $6.06M 10-Q · filed 2026-04-30 | $12.57M derived: sum of 2 quarters · filed 2026-04-30 | $18.51M derived: sum of 3 quarters · filed 2026-04-30 | $25.19M derived: sum of 4 quarters · filed 2026-04-30 | ||||
| 2024-12-31 | $6.51M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | $12.45M derived: sum of 2 quarters · filed 2026-03-03 | $19.14M derived: sum of 3 quarters · filed 2026-03-03 | $25.54M 10-K · filed 2026-03-03 | ||||
| 2024-09-30 | $5.95M 10-Q · filed 2025-11-05 | $7.24M 10-Q · filed 2024-11-04 | $12.63M derived: sum of 2 quarters · filed 2025-11-05 | $19.04M 10-Q · filed 2025-11-05 | $22.81M 10-Q · filed 2024-11-04 | $15.70M derived: sum of 4 quarters · filed 2026-03-03 | ||
| 2024-06-30 | $6.68M 10-Q · filed 2025-07-30 | $7.40M 10-Q · filed 2024-08-08 | $13.09M 10-Q · filed 2025-07-30 | $15.56M 10-Q · filed 2024-08-08 | $9.75M derived: sum of 3 quarters · filed 2026-03-03 | $17.54M derived: sum of 4 quarters · filed 2026-03-03 | ||
| 2024-03-31 | $6.41M 10-Q · filed 2025-05-09 | $8.16M 10-Q · filed 2024-05-08 | $3.07M derived: sum of 2 quarters · filed 2026-03-03 | $10.86M derived: sum of 3 quarters · filed 2026-03-03 | $19.77M derived: sum of 4 quarters · filed 2026-03-03 | |||
| 2023-12-31 | -$3.34M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | $4.45M derived: sum of 2 quarters · filed 2026-03-03 | $13.36M derived: sum of 3 quarters · filed 2026-03-03 | $21.76M 10-K · filed 2026-03-03 | $32.69M 10-K · filed 2024-03-15 | |||
| 2023-09-30 | $7.79M 10-Q · filed 2024-11-04 | $16.70M derived: sum of 2 quarters · filed 2024-11-04 | $25.11M 10-Q · filed 2024-11-04 | $22.99M derived: sum of 4 quarters · filed 2025-03-17 | ||||
| 2023-06-30 | $8.91M 10-Q · filed 2024-08-08 | $17.31M 10-Q · filed 2024-08-08 | $15.20M derived: sum of 3 quarters · filed 2025-03-17 | $22.50M derived: sum of 4 quarters · filed 2025-03-17 | ||||
| 2023-03-31 | $8.40M 10-Q · filed 2024-05-08 | $6.29M derived: sum of 2 quarters · filed 2025-03-17 | $13.59M derived: sum of 3 quarters · filed 2025-03-17 | $20.56M derived: sum of 4 quarters · filed 2025-03-17 | ||||
| 2022-12-31 | -$2.11M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-17 | $5.19M derived: sum of 2 quarters · filed 2025-03-17 | $12.16M derived: sum of 3 quarters · filed 2025-03-17 | $18.32M 10-K · filed 2025-03-17 | $28.18M 10-K · filed 2023-03-16 | |||
| 2022-09-30 | $7.30M 10-Q · filed 2023-11-03 | $14.28M derived: sum of 2 quarters · filed 2023-11-03 | $20.43M 10-Q · filed 2023-11-03 | $26.43M derived: sum of 4 quarters · filed 2024-03-15 | ||||
| 2022-06-30 | $6.97M 10-Q · filed 2023-08-08 | $13.13M 10-Q · filed 2023-08-08 | $19.13M derived: sum of 3 quarters · filed 2024-03-15 | $26.80M derived: sum of 4 quarters · filed 2024-03-15 | ||||
| 2022-03-31 | $6.16M 10-Q · filed 2023-05-09 | $12.16M derived: sum of 2 quarters · filed 2024-03-15 | $19.83M derived: sum of 3 quarters · filed 2024-03-15 | $27.12M derived: sum of 4 quarters · filed 2024-03-15 | ||||
| 2021-12-31 | $6.00M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-15 | $13.67M derived: sum of 2 quarters · filed 2024-03-15 | $20.97M derived: sum of 3 quarters · filed 2024-03-15 | $27.33M 10-K · filed 2024-03-15 | ||||
| 2021-09-30 | $7.67M 10-Q · filed 2022-11-09 | $14.97M derived: sum of 2 quarters · filed 2022-11-09 | $21.33M 10-Q · filed 2022-11-09 | $28.96M derived: sum of 4 quarters · filed 2023-03-16 | ||||
| 2021-06-30 | $7.29M 10-Q · filed 2022-08-04 | $13.65M 10-Q · filed 2022-08-04 | $21.29M derived: sum of 3 quarters · filed 2023-03-16 | $26.50M derived: sum of 4 quarters · filed 2023-03-16 | ||||
| 2021-03-31 | $6.36M 10-Q · filed 2022-05-06 | $13.99M derived: sum of 2 quarters · filed 2023-03-16 | $19.21M derived: sum of 3 quarters · filed 2023-03-16 | $23.74M derived: sum of 4 quarters · filed 2023-03-16 | ||||
| 2020-12-31 | $7.63M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16 | $12.85M derived: sum of 2 quarters · filed 2023-03-16 | $17.38M derived: sum of 3 quarters · filed 2023-03-16 | $23.43M 10-K · filed 2023-03-16 | ||||
| 2020-09-30 | $5.22M 10-Q · filed 2021-11-05 | $9.75M derived: sum of 2 quarters · filed 2021-11-05 | $15.80M 10-Q · filed 2021-11-05 | $19.88M derived: sum of 4 quarters · filed 2022-03-11 | ||||
| 2020-06-30 | $4.53M 10-Q · filed 2021-08-06 | $10.58M 10-Q · filed 2021-08-06 | $14.67M derived: sum of 3 quarters · filed 2022-03-11 | $18.82M derived: sum of 4 quarters · filed 2022-03-11 | ||||
| 2020-03-31 | $6.05M 10-Q · filed 2021-05-07 | $10.13M derived: sum of 2 quarters · filed 2022-03-11 | $14.29M derived: sum of 3 quarters · filed 2022-03-11 | $18.46M derived: sum of 4 quarters · filed 2022-03-11 | ||||
| 2019-12-31 | $4.08M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-11 | $8.24M derived: sum of 2 quarters · filed 2022-03-11 | $12.41M derived: sum of 3 quarters · filed 2022-03-11 | $16.66M 10-K · filed 2022-03-11 | ||||
| 2019-09-30 | $4.16M 10-Q · filed 2020-11-05 | $8.32M derived: sum of 2 quarters · filed 2020-11-05 | $12.58M 10-Q · filed 2020-11-05 | $16.64M derived: sum of 4 quarters · filed 2021-04-26 | ||||
| 2019-06-30 | $4.17M 10-Q · filed 2020-08-07 | $8.42M 10-Q · filed 2020-08-07 | $12.49M derived: sum of 3 quarters · filed 2021-04-26 | $16.72M derived: sum of 4 quarters · filed 2021-04-26 | ||||
| 2019-03-31 | $4.26M 10-Q · filed 2020-05-22 | $8.32M derived: sum of 2 quarters · filed 2021-04-26 | $12.55M derived: sum of 3 quarters · filed 2021-04-26 | $17.29M derived: sum of 4 quarters · filed 2021-04-26 | ||||
| 2018-12-31 | $4.06M derived: 10-K/A 12 month − 10-Q 9 month · filed 2021-04-26 | $8.30M derived: sum of 2 quarters · filed 2021-04-26 | $13.03M derived: sum of 3 quarters · filed 2021-04-26 | $18.19M 10-K/A · filed 2021-04-26 | ||||
| 2018-09-30 | $4.23M 10-Q · filed 2019-10-28 | $8.96M derived: sum of 2 quarters · filed 2019-10-28 | $14.13M 10-Q · filed 2019-10-28 | $18.39M derived: sum of 4 quarters · filed 2020-03-06 | ||||
| 2018-06-30 | $4.73M 10-Q · filed 2019-07-26 | $9.89M 10-Q · filed 2019-07-26 | $14.16M derived: sum of 3 quarters · filed 2020-03-06 | $20.00M derived: sum of 4 quarters · filed 2020-03-06 | ||||
| 2018-03-31 | $5.16M 10-Q · filed 2019-05-06 | $9.43M derived: sum of 2 quarters · filed 2020-03-06 | $15.27M derived: sum of 3 quarters · filed 2020-03-06 | $19.72M derived: sum of 4 quarters · filed 2020-03-06 | ||||
| 2017-12-31 | $4.27M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-06 | $10.11M derived: sum of 2 quarters · filed 2020-03-06 | $14.56M derived: sum of 3 quarters · filed 2020-03-06 | $18.79M 10-K · filed 2020-03-06 | ||||
| 2017-09-30 | $5.84M 10-Q · filed 2018-10-26 | $10.29M derived: sum of 2 quarters · filed 2018-10-26 | $14.52M 10-Q · filed 2018-10-26 | $17.48M derived: sum of 4 quarters · filed 2019-02-27 | ||||
| 2017-06-30 | $4.45M 10-Q · filed 2018-07-31 | $8.68M 10-Q · filed 2018-07-31 | $11.64M derived: sum of 3 quarters · filed 2019-02-27 | $14.46M derived: sum of 4 quarters · filed 2019-02-27 | ||||
| 2017-03-31 | $4.23M 10-Q · filed 2018-05-10 | $7.19M derived: sum of 2 quarters · filed 2019-02-27 | $10.01M derived: sum of 3 quarters · filed 2019-02-27 | $12.80M derived: sum of 4 quarters · filed 2019-02-27 | ||||
| 2016-12-31 | $2.96M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-27 | $5.78M derived: sum of 2 quarters · filed 2019-02-27 | $8.57M derived: sum of 3 quarters · filed 2019-02-27 | $10.73M 10-K · filed 2019-02-27 | ||||
| 2016-09-30 | $2.82M 10-Q · filed 2017-10-27 | $5.61M derived: sum of 2 quarters · filed 2017-10-27 | $7.77M 10-Q · filed 2017-10-27 | $10.79M derived: sum of 4 quarters · filed 2018-02-27 | ||||
| 2016-06-30 | $2.79M 10-Q · filed 2017-07-28 | $4.95M 10-Q · filed 2017-07-28 | $7.97M derived: sum of 3 quarters · filed 2018-02-27 | $10.03M derived: sum of 4 quarters · filed 2018-02-27 | ||||
| 2016-03-31 | $2.16M 10-Q · filed 2017-05-04 | $5.17M derived: sum of 2 quarters · filed 2018-02-27 | $7.24M derived: sum of 3 quarters · filed 2018-02-27 | $9.05M derived: sum of 4 quarters · filed 2018-02-27 | ||||
| 2015-12-31 | $3.02M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | $5.08M derived: sum of 2 quarters · filed 2018-02-27 | $6.89M derived: sum of 3 quarters · filed 2018-02-27 | $8.99M 10-K · filed 2018-02-27 | ||||
| 2015-09-30 | $2.06M 10-Q · filed 2016-11-01 | $2.06M 10-Q · filed 2015-11-03 | $3.87M derived: sum of 2 quarters · filed 2016-11-01 | $5.97M 10-Q · filed 2016-11-01 | $5.97M 10-Q · filed 2015-11-03 | $7.95M derived: sum of 4 quarters · filed 2017-02-24 | ||
| 2015-06-30 | $1.81M 10-Q · filed 2016-08-01 | $1.81M 10-Q · filed 2015-08-04 | $3.91M 10-Q · filed 2016-08-01 | $3.91M 10-Q · filed 2015-08-04 | $5.89M derived: sum of 3 quarters · filed 2017-02-24 | $7.89M derived: sum of 4 quarters · filed 2017-02-24 | ||
| 2015-03-31 | $2.10M 10-Q · filed 2016-05-03 | $2.10M 10-Q · filed 2015-05-04 | $4.08M derived: sum of 2 quarters · filed 2017-02-24 | $6.08M derived: sum of 3 quarters · filed 2017-02-24 | $7.95M derived: sum of 4 quarters · filed 2017-02-24 | |||
| 2014-12-31 | $1.98M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-24 | $3.98M derived: sum of 2 quarters · filed 2017-02-24 | $5.86M derived: sum of 3 quarters · filed 2017-02-24 | $8.14M 10-K · filed 2017-02-24 | $8.14M 10-K · filed 2015-03-13 | |||
| 2014-09-30 | $2.00M 10-Q · filed 2015-11-03 | $3.87M derived: sum of 2 quarters · filed 2015-11-03 | $6.16M 10-Q · filed 2015-11-03 | $8.19M derived: sum of 4 quarters · filed 2016-03-10 | ||||
| 2014-06-30 | $1.87M 10-Q · filed 2015-08-04 | $4.16M 10-Q · filed 2015-08-04 | $6.19M derived: sum of 3 quarters · filed 2016-03-10 | $7.81M derived: sum of 4 quarters · filed 2016-03-10 | ||||
| 2014-03-31 | $2.29M 10-Q · filed 2015-05-04 | $4.32M derived: sum of 2 quarters · filed 2016-03-10 | $5.94M derived: sum of 3 quarters · filed 2016-03-10 | $7.76M derived: sum of 4 quarters · filed 2016-03-10 | ||||
| 2013-12-31 | $2.03M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-10 | $3.65M derived: sum of 2 quarters · filed 2016-03-10 | $5.48M derived: sum of 3 quarters · filed 2016-03-10 | $7.06M 10-K · filed 2016-03-10 | $7.06M 10-K · filed 2014-03-13 | |||
| 2013-09-30 | $1.62M 10-Q · filed 2014-11-06 | $3.45M derived: sum of 2 quarters · filed 2014-11-06 | $5.03M 10-Q · filed 2014-11-06 | $6.37M derived: sum of 4 quarters · filed 2015-03-13 | ||||
| 2013-06-30 | $1.83M 10-Q · filed 2014-08-04 | $3.41M 10-Q · filed 2014-08-04 | $4.75M derived: sum of 3 quarters · filed 2015-03-13 | $5.97M derived: sum of 4 quarters · filed 2015-03-13 | ||||
| 2013-03-31 | $1.58M 10-Q · filed 2014-05-05 | $2.92M derived: sum of 2 quarters · filed 2015-03-13 | $4.14M derived: sum of 3 quarters · filed 2015-03-13 | $5.44M derived: sum of 4 quarters · filed 2015-03-13 | ||||
| 2012-12-31 | $1.34M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-13 | $2.56M derived: sum of 2 quarters · filed 2015-03-13 | $3.85M derived: sum of 3 quarters · filed 2015-03-13 | $5.39M 10-K · filed 2015-03-13 | ||||
| 2012-09-30 | $1.22M 10-Q · filed 2013-11-05 | $2.52M derived: sum of 2 quarters · filed 2013-11-05 | $4.05M 10-Q · filed 2013-11-05 | $5.58M derived: sum of 4 quarters · filed 2014-03-13 | ||||
| 2012-06-30 | $1.30M 10-Q · filed 2013-08-06 | $2.83M 10-Q · filed 2013-08-06 | $4.36M derived: sum of 3 quarters · filed 2014-03-13 | $5.89M derived: sum of 4 quarters · filed 2014-03-13 | ||||
| 2012-03-31 | $1.53M 10-Q · filed 2013-05-06 | $3.06M derived: sum of 2 quarters · filed 2014-03-13 | $4.60M derived: sum of 3 quarters · filed 2014-03-13 | $6.17M derived: sum of 4 quarters · filed 2014-03-13 | ||||
| 2011-12-31 | $1.53M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-13 | $3.06M derived: sum of 2 quarters · filed 2014-03-13 | $4.64M derived: sum of 3 quarters · filed 2014-03-13 | $6.17M 10-K · filed 2014-03-13 | ||||
| 2011-09-30 | $1.53M 10-Q · filed 2012-11-08 | $3.11M derived: sum of 2 quarters · filed 2012-11-08 | $4.64M 10-Q · filed 2012-11-08 | $6.03M derived: sum of 4 quarters · filed 2013-03-14 | ||||
| 2011-06-30 | $1.57M 10-Q · filed 2012-08-07 | $3.11M 10-Q · filed 2012-08-07 | $4.49M derived: sum of 3 quarters · filed 2013-03-14 | $6.27M derived: sum of 4 quarters · filed 2013-03-14 | ||||
| 2011-03-31 | $1.53M 10-Q · filed 2012-05-07 | $2.92M derived: sum of 2 quarters · filed 2013-03-14 | $4.70M derived: sum of 3 quarters · filed 2013-03-14 | $6.53M derived: sum of 4 quarters · filed 2013-03-14 | ||||
| 2010-12-31 | $1.39M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-14 | $3.16M derived: sum of 2 quarters · filed 2013-03-14 | $5.00M derived: sum of 3 quarters · filed 2013-03-14 | $6.87M 10-K · filed 2013-03-14 | ||||
| 2010-09-30 | $1.77M 10-Q · filed 2011-11-04 | $3.61M derived: sum of 2 quarters · filed 2011-11-04 | $5.49M 10-Q · filed 2011-11-04 | |||||
| 2010-06-30 | $1.84M 10-Q/A · filed 2011-08-10 | $3.71M 10-Q/A · filed 2011-08-10 | ||||||
| 2009-12-31 | $8.18M 10-K · filed 2012-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |